Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine (Fluarix™) Administered Intramuscularly in Adults

NCT00363870 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00363870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00363870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine (Fluarix™) Administered Intramuscularly in Adults
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
June 30, 2007
Enrollment
7,632
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

influenza